Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201202120 Principal Investigator: Van Tine, Brian
Title: A prospective, multicenter, randomized, open-label, active-controlled, two-parallel groups, phase 3 study to compare the efficacy and safety of masitinib to sunitinib in patients with gastrointestinal stromal tumor resistant to imatinib
Phase: III Disease Site: Multiple Sites
Participating Site(s):
 
Main Campus
Map and Directions
St. Peters
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this research study is to compare the efficacy and safety of a drug called masitinib to those of a standard treatment for GIST called sunitinib.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)